4 January 2018
FEDERAL GOVERNMENT TO ALLOW CANNABIS EXPORT
AusCann Group Holdings Ltd (ASX:AC8) (“AusCann” or “the Company”) welcomes the
Federal Government announcement today from Health Minister Greg Hunt to allow
manufactured cannabinoid medicines to be exported from Australia.
This puts AusCann in a very valuable position as the only company with the full set of the
necessary licences to grow and manufacture cannabinoid medicines in Australia. AusCann
has the only established TGA licensed manufacturing facility through their partnership with
Tasmanian Alkaloids.
AusCann, Managing Director Elaine Darby said “This is a win for the Australian Cannabis
industry and Australian patients as it allows us to produce cost effective products at scale.
We are perfectly positioned to create high value export products from AusCann and have
the international relationships in place including Canopy, the largest producer in North
America and also our largest shareholder in AusCann.”
“AusCann remains committed to Australian patients as a priority and has developed the
medical outreach program that is already educating doctors and health practitioners in
Australia on the use of cannabinoid medicines.”
-ENDSFor
more information please contact
AusCann
Elaine Darby
Managing Director
elaine.darby@auscann.com.au
+61 458 372 511
For Media Enquiries
Caroline Zielinski
Media & Capital Partners
Caroline.zielinski@mcpartners.com.au
+61 400 172 145
ABOUT AUSCANN GROUP
AusCann is an Australian based company that was incorporated in September 2014 with the aim of
producing and providing high quality, economical and clinically validated cannabinoid medicines to
patients. It is bringing together leading expertise and operations across all aspects of the medical cannabis
value chain, beginning with cultivation and production, through to manufacture and distribution of final
dose form medications and has built a strong team of experts and partners with international connections.
Partners include TSX listed Canopy Growth Corporation the largest producer of medicinal cannabis
globally, DayaCann, the only licensed medicinal cannabis grower in Chile and Tasmanian Alkaloids,
producer of approximately 40% of the worlds opiate supply.
Zurück
